Medtronic Names CFO for Diabetes Spinoff

Medtronic names CFO for diabetes spinoff

The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.

Medtronic Names CFO For Diabetes Spinoff - Data Intelligence

Name: Chad Spooner New Title: CFO, MiniMed Previous Title: CFO, BIC Medtronic has named Chad Spooner CFO of its diabetes business, beginning July 14. Medtronic plans to spin out the segment into a separate, publicly traded company called MiniMed, with the goal of completing the deal within 18 months.  Spooner has more than 25 years of experience in financial leadership, according to the Tuesday announcement. He was previously CFO of consumer goo…

Medtronic Diabetes names CFO with consumer experience

Future MiniMed/Medtronic Diabetes CFO Chad Spooner. [Image from LinkedIn]Medtronic (NYSE:MDT) announced today that it appointed Chad Spooner as CFO of MiniMed in advance of its intended separation. Effective July 14, Spooner takes responsibility for overseeing the finance function for Medtronic Diabetes/MiniMed. His role includes supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as the unit prepares …

Medtronic (NYSE:MDT) Prepares for Diabetes Unit Spin-Off with New CFO Appointment

Medtronic (NYSE:MDT) experienced a price increase of 7% over the last quarter, which may have been influenced by notable corporate developments and robust financial performance. The company announced Chad Spooner's appointment as CFO of MiniMed, a step vital for its separation initiative. Medtronic's financial results showed solid growth, with annual sales rising to $33,537 million and net income reaching $4,662 million. Meanwhile, its dividend …